Barbara Lenz

1.2k total citations
34 papers, 790 citations indexed

About

Barbara Lenz is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Barbara Lenz has authored 34 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Immunology and 4 papers in Oncology. Recurrent topics in Barbara Lenz's work include RNA Interference and Gene Delivery (8 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (5 papers). Barbara Lenz is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Immunotherapy and Immune Responses (7 papers) and Immune Cell Function and Interaction (5 papers). Barbara Lenz collaborates with scholars based in United States, Switzerland and Germany. Barbara Lenz's co-authors include James E. Talmadge, Mark Schneider, Hamblin Phillips, David H. Walker, R Pennington, Cedric W. Long, Georg Schmitt, Henry R. Tribble, Robin Pennington and Margaret S. Collins and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Microbiology and Journal of Medicinal Chemistry.

In The Last Decade

Barbara Lenz

33 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Lenz United States 14 280 223 149 97 89 34 790
Mairi McGrath Germany 13 290 1.0× 507 2.3× 169 1.1× 101 1.0× 18 0.2× 20 1.1k
Ann-Katrin Hopp Switzerland 12 272 1.0× 204 0.9× 159 1.1× 29 0.3× 30 0.3× 20 757
Lauren E. Woodard United States 20 555 2.0× 89 0.4× 122 0.8× 71 0.7× 34 0.4× 40 960
Heleen Vreeling‐Sindelárová Netherlands 13 455 1.6× 100 0.4× 92 0.6× 53 0.5× 23 0.3× 15 1.1k
Chahrazed El Hamel France 12 956 3.4× 168 0.8× 70 0.5× 42 0.4× 80 0.9× 25 1.3k
Joydeep Ghosh United States 22 489 1.7× 276 1.2× 99 0.7× 42 0.4× 37 0.4× 46 1.3k
Chuanping Wang United States 18 1.1k 4.0× 368 1.7× 72 0.5× 39 0.4× 182 2.0× 30 1.6k
Mingkuan Chen China 11 571 2.0× 304 1.4× 78 0.5× 16 0.2× 64 0.7× 13 851
Carole Zanin France 5 746 2.7× 378 1.7× 124 0.8× 43 0.4× 12 0.1× 9 1.3k
Emma J. Petrie Australia 21 1.1k 4.0× 605 2.7× 182 1.2× 30 0.3× 59 0.7× 27 1.6k

Countries citing papers authored by Barbara Lenz

Since Specialization
Citations

This map shows the geographic impact of Barbara Lenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Lenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Lenz more than expected).

Fields of papers citing papers by Barbara Lenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Lenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Lenz. The network helps show where Barbara Lenz may publish in the future.

Co-authorship network of co-authors of Barbara Lenz

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Lenz. A scholar is included among the top collaborators of Barbara Lenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Lenz. Barbara Lenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Petzsche, Moritz Roman Hernández, Qiuyue Ma, Helen Liapis, et al.. (2020). Only Hyperuricemia with Crystalluria, but not Asymptomatic Hyperuricemia, Drives Progression of Chronic Kidney Disease. Journal of the American Society of Nephrology. 31(12). 2773–2792. 97 indexed citations
3.
Lenz, Barbara, et al.. (2020). Combined cSLO-OCT imaging as a tool in preclinical ocular toxicity testing: A comparison to standard in-vivo and pathology methods. Journal of Pharmacological and Toxicological Methods. 104. 106873–106873. 6 indexed citations
4.
Lenz, Barbara, Andreas Brink, Michael J. Mihatsch, et al.. (2020). Multiorgan Crystal Deposition of an Amphoteric Drug in Rats Due to Lysosomal Accumulation and Conversion to a Poorly Soluble Hydrochloride Salt. Toxicological Sciences. 180(2). 383–394. 4 indexed citations
5.
Boess, Franziska, Barbara Lenz, Juergen Funk, et al.. (2017). Use of early phenotypic in vivo markers to assess human relevance of an unusual rodent non-genotoxic carcinogen in vitro. Toxicology. 379. 48–61. 2 indexed citations
6.
Festag, Matthias, Kamille Dumong Erichsen, R. B. R. Persson, et al.. (2017). The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded Oligonucleotides. Toxicological Sciences. 157(1). kfx025–kfx025. 8 indexed citations
7.
Fischer, Holger, M. Csató, Lucette Doessegger, et al.. (2011). In Silico Assay for Assessing Phospholipidosis Potential of Small Druglike Molecules: Training, Validation, and Refinement Using Several Data Sets. Journal of Medicinal Chemistry. 55(1). 126–139. 34 indexed citations
8.
9.
Góralczyk, Regina, et al.. (2005). β-Carotene interaction with NNK in the AJ-mouse model: Effects on cell proliferation, tumor formation and retinoic acid responsive genes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1740(2). 179–188. 12 indexed citations
10.
Schweizer, Anja, Olivier Valdenaire, Anja Köster, et al.. (1999). Neonatal Lethality in Mice Deficient in XCE, a Novel Member of the Endothelin-converting Enzyme and Neutral Endopeptidase Family. Journal of Biological Chemistry. 274(29). 20450–20456. 51 indexed citations
11.
Lenz, Barbara. (1994). Metastasizing Adenocarcinoma of the Cecum in a Squirrel Monkey (Saimiri sciureus). Veterinary Pathology. 31(2). 276–278. 1 indexed citations
12.
Talmadge, James E., Barbara Lenz, Mark Schneider, Hamblin Phillips, & Cedric W. Long. (1989). Immunomodulatory and therapeutic properties of FK-565 in mice. Cancer Immunology Immunotherapy. 28(2). 93–100. 12 indexed citations
13.
Lenz, Barbara, et al.. (1989). Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis. Cancer Immunology Immunotherapy. 29(1). 1–6. 9 indexed citations
14.
Talmadge, James E., et al.. (1988). Immunomodulatory properties of recombinant murine and human tumor necrosis factor.. PubMed. 48(3). 544–50. 119 indexed citations
15.
Lenz, Barbara, et al.. (1988). Protective monoclonal antibodies recognize heat-labile epitopes on surface proteins of spotted fever group rickettsiae. Infection and Immunity. 56(10). 2587–2593. 64 indexed citations
16.
Hartmann, D, Mark Schneider, Barbara Lenz, & James E. Talmadge. (1987). Toxicity of Polyinosinic-Polycytidylic Acid Admixed with Poly-<i>L</i>-Lysine and Solubilized with Carboxymethylcellulose in Mice. Pathology and Immunopathology Research. 6(1). 37–50. 16 indexed citations
17.
Li, Huijun, et al.. (1987). Barbash strain spotted fever group rickettsia is a strain of Rickettsia conorii and differs from Rickettsia sibirica.. PubMed. 31(6). 489–98. 6 indexed citations
18.
Talmadge, James E., Hamblin Phillips, Margaret S. Collins, et al.. (1985). Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.. PubMed. 45(3). 1058–65. 42 indexed citations
19.
Talmadge, James E., Hamblin Phillips, Margaret S. Collins, et al.. (1985). Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.. PubMed. 45(3). 1066–72. 27 indexed citations
20.
Talmadge, James E., et al.. (1984). The effect of experimental conditions on the assessment of T cell immunomodulation by biological response modifiers (thymosin fraction five). Immunopharmacology. 7(1). 17–26. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mairi McGrath Breakdown of academic impact, for papers by Ann-Katrin Hopp Breakdown of academic impact, for papers by Lauren E. Woodard Breakdown of academic impact, for papers by Heleen Vreeling‐Sindelárová Breakdown of academic impact, for papers by Chahrazed El Hamel Breakdown of academic impact, for papers by Joydeep Ghosh Breakdown of academic impact, for papers by Chuanping Wang Breakdown of academic impact, for papers by Mingkuan Chen Breakdown of academic impact, for papers by Carole Zanin Breakdown of academic impact, for papers by Emma J. Petrie
Rankless by CCL
2026